MENU
+Compare
BMED
ETF ticker: NYSE ARCA
AS OF
Aug 26, 04:26 PM (EDT)
Price
$25.99
Change
+$0.09 (+0.35%)
Net Assets
4.21M

BMED stock forecast, quote, news & analysis

The investment seeks to maximize total return... Show more

Category: #Health
BMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BMED with price predictions
Aug 25, 2025

BMED sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BMED moved above the 200-day moving average on August 22, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on BMED as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BMED just turned positive on August 14, 2025. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

BMED moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 259 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BMED moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Market Cap

The average market capitalization across the iShares Health Innovation Active ETF ETF is 32.08B. The market cap for tickers in the group ranges from 107.82M to 429.67B. JNJ holds the highest valuation in this group at 429.67B. The lowest valued company is TCRX at 107.82M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 21%. For the same ETF, the average monthly price growth was 53%, and the average quarterly price growth was 208%. ALLO experienced the highest price growth at 6%, while VKTX experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was -23%. For the same stocks of the ETF, the average monthly volume growth was -27% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 76
Price Growth Rating: 53
SMR Rating: 76
Profit Risk Rating: 81
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
BMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
BlackRock ETF Trust100 BELLEVUE PARKWAY
Phone
N/A
Web
www.blackrock.com